AstraZeneca R&D Center
Sector: Pharmaceutical • Location: China
Source: Site Selection Magazine
AstraZeneca plans to establish a second global strategic R&D center in Beijing, China, with a $2.5 billion investment. This center will focus on developing vaccines and innovative medicines, leveraging the local life sciences ecosystem.
- Status
- Prospective
- Sector
- Pharmaceutical
- Location
- China
- Updated
- 22 Jul 2026
- Source
- Site Selection Magazine
ConstructChat
Ask ConstructChat about AstraZeneca R&D Center
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | Planned |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | AstraZeneca plans to establish a second global strategic R&D center in Beijing, China, with a $2.5 billion investment. This center will focus on developing vaccines and innovative medicines, leveraging the local life sciences ecosystem. |
Original sector | Pharmaceutical |
Budget |
Location
Country | China |
Source
Source | Site Selection Magazine |
URL |
More Details
Record type | Project |
Article published date | 2025-04-18 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project